Alidabio is a company that specializes in providing innovative solutions in the field of biotechnology. The company focuses on developing and commercializing products and services that cater to the needs of the healthcare and life sciences sectors.

Alidabio

Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.

Alida Biosciences

Introducing the EpiPlex™ RNA Reagent Kit: Multiplexed Epigenomics has arrived!

We are excited to announce the early access launch of the EpiPlex RNA Assay, designed to empower researchers with unprecedented insights into Epitranscriptomics. Say goodbye to the limitations of existing methods and embrace a new era of accuracy, sensitivity, and ease in epitranscriptomic analysis.

Key Features of the EpiPlex RNA Reagent Kit:
✅ Multiplexed Detection: Our proximity barcoding-based assay enables simultaneous detection of multiple RNA modifications in mRNA and long ncRNA.
✅ High Sensitivity: With a sensitivity that allows for analysis of clinical samples using just 20 ng of mRNA input, our assay ensures reliable results even with limited starting material.
✅ Enhanced Quantitative Analysis: Using next-gen sequencing as a readout, the assay reports on RNA modification identity, location, and relative quantification at each locus.
✅ Streamlined Workflow: The multiplexed assay design reduces variability across experiments and the user-friendly customer pipeline to analyze the new data types makes the epitranscriptome as accessible as traditional RNA-Seq.
✅ Early Access Availability: Be among the first to experience the power of multiplexed epigenomics! The EpiPlex RNA Assay is now available as an early access reagent kit, putting cutting-edge technology at your fingertips.

Unlock the Potential of Epitranscriptomics with Alida Bio.

Contact us at orders@alidabio.com today to learn more about the EpiPlex RNA Reagent Kit and begin your journey toward groundbreaking discoveries in epitranscriptomics!
#Epitranscriptomics #RNAmodifications #EpiPlex #RNASeq #AlidaBio #Epigenomics

 


COM:ALIDABIO

Alidabio

Financials Not Available